Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders.
Bock
Oliver
O
Schlué
Jerome
J
Kreipe
Hans
H
D001854:Bone Marrow Cells / Q000378:metabolism*; D002908:Chronic Disease; D005786:Gene Expression Regulation; D018392:Genomic Imprinting; D006410:Hematopoiesis; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000378:metabolism; D015477:Leukemia, Myelomonocytic, Chronic / Q000235:genetics / Q000378:metabolism; D009196:Myeloproliferative Disorders / Q000235:genetics / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics; D062085:RNA, Long Noncoding; D012334:RNA, Neoplasm / Q000096:biosynthesis; D022661:RNA, Untranslated / Q000096:biosynthesis* / Q000235:genetics
C094335:H19 long non-coding RNA; D009363:Neoplasm Proteins; D062085:RNA, Long Noncoding; D012334:RNA, Neoplasm; D022661:RNA, Untranslated; D007335:Insulin-Like Growth Factor II